Next Article in Journal
Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD
Next Article in Special Issue
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
Previous Article in Journal
A ‘Furry-Tale’ of Zika Virus Infection: What Have We Learned from Animal Models?
Previous Article in Special Issue
HCV-Specific T Cell Responses During and After Chronic HCV Infection
 
 
Review

Article Versions Notes

Viruses 2019, 11(1), 30; https://doi.org/10.3390/v11010030
Action Date Notes Link
article xml file uploaded 6 January 2019 04:50 CET Original file -
article xml uploaded. 6 January 2019 04:50 CET Update https://www.mdpi.com/1999-4915/11/1/30/xml
article pdf uploaded. 6 January 2019 04:50 CET Version of Record https://www.mdpi.com/1999-4915/11/1/30/pdf
article html file updated 6 January 2019 04:52 CET Original file -
article html file updated 29 January 2019 05:43 CET Update -
article html file updated 2 April 2019 22:40 CEST Update -
article html file updated 13 April 2019 06:54 CEST Update -
article html file updated 27 April 2019 10:56 CEST Update -
article html file updated 12 October 2019 22:18 CEST Update -
article html file updated 11 February 2020 06:56 CET Update -
article html file updated 17 July 2022 21:20 CEST Update https://www.mdpi.com/1999-4915/11/1/30/html
Back to TopTop